284 related articles for article (PubMed ID: 16685587)
1. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
[TBL] [Abstract][Full Text] [Related]
2. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.
Lerner-Geva L; Rabinovici J; Olmer L; Blumstein T; Mashiach S; Lunenfeld B
Gynecol Endocrinol; 2012 Oct; 28(10):809-14. PubMed ID: 22475084
[TBL] [Abstract][Full Text] [Related]
3. The possible association between IVF and breast cancer incidence.
Pappo I; Lerner-Geva L; Halevy A; Olmer L; Friedler S; Raziel A; Schachter M; Ron-El R
Ann Surg Oncol; 2008 Apr; 15(4):1048-55. PubMed ID: 18214616
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Gynecol Oncol; 1996 Jan; 60(1):3-7. PubMed ID: 8557223
[TBL] [Abstract][Full Text] [Related]
8. Childhood tumor risk after treatment with ovulation-stimulating drugs.
Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
[TBL] [Abstract][Full Text] [Related]
9. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
Venn A; Watson L; Bruinsma F; Giles G; Healy D
Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
[TBL] [Abstract][Full Text] [Related]
10. In vitro fertilization and breast cancer risk: a review.
Salhab M; Al Sarakbi W; Mokbel K
Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
[TBL] [Abstract][Full Text] [Related]
11. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
[TBL] [Abstract][Full Text] [Related]
12. Uterine cancer after use of clomiphene citrate to induce ovulation.
Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
[TBL] [Abstract][Full Text] [Related]
13. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
Kashyap S; Moher D; Fung MF; Rosenwaks Z
Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
[TBL] [Abstract][Full Text] [Related]
14. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis.
Beebeejaun Y; Athithan A; Copeland TP; Kamath MS; Sarris I; Sunkara SK
Fertil Steril; 2021 Jul; 116(1):198-207. PubMed ID: 34148584
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer and Ovulation Induction Treatments.
Taheripanah R; Balash F; Anbiaee R; Mahmoodi M; Akbari Sene A
Clin Breast Cancer; 2018 Oct; 18(5):395-399. PubMed ID: 29628340
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
van den Belt-Dusebout AW; Spaan M; Lambalk CB; Kortman M; Laven JS; van Santbrink EJ; van der Westerlaken LA; Cohlen BJ; Braat DD; Smeenk JM; Land JA; Goddijn M; van Golde RJ; van Rumste MM; Schats R; Józwiak K; Hauptmann M; Rookus MA; Burger CW; van Leeuwen FE
JAMA; 2016 Jul; 316(3):300-12. PubMed ID: 27434442
[TBL] [Abstract][Full Text] [Related]
17. Ovulation induction for infertility is it safe or not?
Anderson SM; Dimitrievich E
S D J Med; 1996 Nov; 49(11):419-21. PubMed ID: 8973135
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of fertility agents and risk of breast cancer: a recent update for an old problem.
Tomao F; Lo Russo G; Spinelli GP; Tomao S
Curr Opin Obstet Gynecol; 2014 Jun; 26(3):130-7. PubMed ID: 24751999
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction treatment and risk of borderline ovarian tumors.
Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
[TBL] [Abstract][Full Text] [Related]
20. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
